TerminatedNot Applicable

Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)

Stopped: Study no longer pursued.

Albania, Egypt, Georgia20 participantsStarted 2018-08-01

Plain-language summary

International, multicenter, observational, longitudinal study to identify biomarker/s for Tuberous Sclerosis Complex and to explore the clinical robustness, specificity, and long´-term variability of these biomarker/s

Who can participate

Age range2 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

INCLUSION CRITERIA * Informed consent is obtained from the participant or from the parent / legal guardian * Participant is aged between 2 and 50 years * Diagnosis of TSC is genetically confirmed by CENTOGENE EXCLUSION CRITERIA * Inability to provide informed consent * Participant is younger than 2 or older than 50 years * Diagnosis of TSC is not genetically confirmed by CENTOGENE

What they're measuring

Identification of TSC biomarker/s

Timeframe: 36 months

Trial details

NCT IDNCT02654340

SponsorCENTOGENE GmbH Rostock

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2022-12-30

View on ClinicalTrials.gov More Hypomelanotic Macules trials